Rocket


News + Filings
Holdings


All
13F
13D/G
Other

Soleus Capital Master Fund, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 SC 13G Soleus Capital Master Fund, L.P. reports a 5.3% stake in Delcath Systems, Inc.
08/11/2023 SC 13G Soleus Capital Master Fund, L.P. reports a 8.2% stake in Axogen, Inc.
07/27/2023 SC 13G Soleus Capital Master Fund, L.P. reports a 5.1% stake in Verastem, Inc.
04/14/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/22/2023 SC 13G Soleus Capital Master Fund, L.P. reports a 5.3% stake in RIGEL PHARMACEUTICALS INC.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Soleus Capital Master Fund, L.P. reports a 14% stake in EDAP TMS S.A.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Soleus Capital Master Fund, L.P. reports a 0% stake in APOLLO ENDOSURGERY, INC.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Soleus Capital Master Fund, L.P. reports a 9.9% stake in CELCUITY INC.
01/30/2023 SC 13G Soleus Capital Master Fund, L.P. reports a 5.7% stake in JASPER THERAPEUTICS, INC.
01/27/2023 SC 13G Soleus Capital Master Fund, L.P. reports a 5.4% stake in PIERIS PHARMACEUTICALS, INC.
01/26/2023 SC 13G/A Soleus Capital Master Fund, L.P. reports a 1.3% stake in PIERIS PHARMACEUTICALS, INC.
11/14/2022 SC 13G/A Soleus Capital Master Fund, L.P. reports a 10% stake in THERATECHNOLOGIES, INC.
10/13/2022 SC 13G Soleus Capital Master Fund, L.P. reports a 5.1% stake in Organogenesis Holdings Inc.
09/28/2022 SC 13G/A Soleus Capital Master Fund, L.P. reports a 13.4% stake in EDAP TMS S.A.
09/02/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/02/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/01/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
05/18/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2022 SC 13G/A Soleus Capital Master Fund, L.P. reports a 9.4% stake in EDAP TMS S.A.
02/10/2022 SC 13G/A Soleus Capital Master Fund, L.P. reports a 9.6% stake in THERATECHNOLOGIES, INC.
02/10/2022 SC 13G/A Soleus Capital Master Fund, L.P. reports a 5.8% stake in APOLLO ENDOSURGERY, INC.
01/27/2022 SC 13G Soleus Capital Master Fund, L.P. reports a 5.4% stake in PIERIS PHARMACEUTICALS, INC.
12/20/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/23/2021 SC 13G Soleus Capital Master Fund, L.P. reports a 7.8% stake in THERATECHNOLOGIES, INC.
05/15/2020 4 Soleus Private Equity GP I, LLC (10% Owner) has filed a Form 4 on Lyra Therapeutics, Inc.
Txns: Converted 338,330 shares @ $0
Converted 104,608 shares @ $0
Sold 16,909 shares @ $16, valued at $270.5k
Bought 155,000 shares @ $16, valued at $2.5M
Converted 11,666,666 convertible preferred @ $0
Converted 3,607,224 convertible preferred @ $0
Exercised (in-or-at-the-money) 31,382 warrants @ $8.63, valued at $270.8k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy